Skip to Content

CL 23 (Fenofibrate (micronized) 134 mg)

Pill with imprint CL 23 is Yellow & White, Capsule-shape and has been identified as Fenofibrate (micronized) 134 mg. It is supplied by Alvogen, Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for CL 23

Fenofibrate (micronized)

Imprint:
CL 23
Strength:
134 mg
Color:
Yellow & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Alvogen, Inc.
National Drug Code (NDC):
47781-0519

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide